Related Experiment Videos
[Silicone breast implants and breast cancer]
J Y Petit1, M Rietjens, M G Le
1Institut Gustave-Roussy (IGR), Villejuif, France.
Annales De Chirurgie Plastique Et Esthetique
|April 1, 1997
Summary
Silicone gel breast implants pose no increased oncological risk for breast reconstruction patients. A comparative study found no differences in survival, recurrence, or metastasis rates compared to controls.
Area of Science:
- Oncology
- Immunology
- Plastic Surgery
Background:
- Breast reconstruction commonly utilizes silicone gel implants.
- Assessing the long-term oncological and immunological risks associated with these implants is crucial.
Purpose of the Study:
- To evaluate the immunological and oncological risks of prefilled silicone gel breast implants.
- To compare outcomes in patients undergoing breast reconstruction with silicone implants versus matched controls.
Main Methods:
- Comparative study design.
- Inclusion of 146 patients undergoing breast reconstruction with silicone implants.
- Inclusion of 146 matched control patients.
Main Results:
- No significant difference in overall survival between implant and control groups.
- No significant difference in local recurrence rates.
- No significant difference in the rate of distant metastases.
Conclusions:
- Prefilled silicone gel breast implants do not appear to increase the oncological risk in breast reconstruction.
- Further long-term immunological surveillance may be warranted.